Attenuation of reperfusion injury by renal ischemic postconditioning: The role of NO

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 628-634

  Liu, Xiuheng ^a   Chen, Hui ^a   Zhan, Bingyan ^a   Xing, Bianzhi ^b   Zhou, Jiangqiao ^a   Zhu, Hengcheng ^a   Chen, Zhiyuan ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

eNOS; ET 1; iNOS; Ischemia; Ischemic postconditioning; Kidney; NO

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; MALE; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; ENDOTHELIN-1; GENE EXPRESSION REGULATION; ISCHEMIC PRECONDITIONING; KIDNEY DISEASES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER;

RATTUS;

EID: 34250180226     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.129     Document Type: Article

References (37)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. Schott R.J., Rohmann S., and Braun E.R. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 66 (1990) 1133-11424
3. 2 deprivation injury, possibly by inducing uremia. Kidney Int. 45 (1994) 1760-1768
4. Park K.M., Chen A., and Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 276 (2001) 11870-11876
5. Toosy N., McMorris E.L., and Grace P.A. Ischemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 84 (1999) 489-494
6. Jefayri M.K., Grace P.A., and Mathie R.T. Attenuation of reperfusion injury by renal ischemic preconditioning: the role of nitric oxide. BJU Int. 85 (2000) 1007-1013
7. Lee H.T., and Emala C.W. Protein kinase C and Gi/o proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J. Am. Soc. Nephrol. 12 (2001) 233-240
8. Torras J., Herrero-Fresneda I., and Lloberas N. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 61 (2002) 2218-2227
9. Zhao Z.Q., and Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc. Res. 70 (2006) 200-211
10. Zhao Z.Q., Corvera J.S., and Halkos M.E. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditionin. Am. J. Physiol. 285 (2003) 579-588
11. Gumina R.J., and Gross G.J. If ischemic preconditioning is the gold standard, has a platinum standard of cardio protection arrived? Comparison with NHE inhibition. J. Thromb. Thrombolysis. 8 (1999) 39-44
12. Tsang A., Hausenloy D.J., and Mocanu M.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway. Circ. Res. 95 (2004) 230-232
13. Kin H., Zhao Z.Q., and Sun H.Y. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 62 (2004) 74-85
14. Kin H., Zatta A.J., Lofye M.T., and Amerson B.S. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc. Res. 67 (2005) 124-133
15. 2+ overload. Am. J. Physiol. Heart. Circ. Physiol. 288 (2005) 1900-1908
16. Bopassa J.C., Ferrera R., and Gateau-Roesch O. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and Postconditioning. Cardiovasc. Res. 69 (2006) 178-185
17. Zhao H., Sapolsky R.M., and Steinberg G.K. Interrupting reperfusion as a stroke therapy: ischemic Postconditioning reduces infarct size after focal ischemia in rats. J. Cereb. Blood. Flow. Metab. 26 (2006) 1114-1121
18. Sun K., Liu Z.S., and Sun Q. Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic Postconditioning. World J. Gastroenterol. 10 (2004) 1934-1938
19. Yang X.M., Philipp S., and Downey J.M. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Bas. Res. Cardiol. 100 (2005) 57-63
20. Johnson G., Tsao P.S., and Lefer A.M. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit. Care. Med. 19 (1991) 244-252
21. Lefer D.J., Nakanishi K., and Johnston W.E. Antineutrophil and myocardial protecting action of SPM-5185, a novel nitric oxide (NO) donor, following acute myocardial ischemia and reperfusion in dogs. Circulation 88 (1993) 2337-2350
22. Yang X.M., Proctor J.B., and Cui L. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44 (2004) 1103-1110
23. Jablonski P., Howden B.O., and Rae D.A. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35 (1983) 198-204
24. Parka K.M., Choa H.J., and Bonventre J.V. Orchiectomy reduces susceptibility to renal ischemic injury: a role for heat shock proteins. Biochem. Biophys. Res. Commun. 328 (2005) 312-317
25. Shoskes D.A., Xie Y., and Gonzalez-Cadavid N.F. Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat: implications for renal transplantation. Transplantation 63 (1997) 495-500
26. Noiri E., Peresleni T., and Miller F. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97 (1996) 2377-2383
27. Chiao H., Kohda Y., and McLeroy P. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99 (1997) 1165-1172
28. Goligorsky M.S., Brodsky S.V., and Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 61 (2002) 855-861
29. Thadhani R., Pascual M., and Bonventre J.V. Acute renal failure. N. Engl. J. Med. 334 (1996) 1448-1460
30. Chintala M.S., Chin P.J.S., and Vemulapalli S. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol. 348 (1993) 305-310
31. Ogawa T., Nussler A.K., and Tuzuner E. Contribution of nitric oxide to the protective effects of ischemic preconditioning in ischemia-reperfused rat kidneys. J. Lab. Clin. Med. 138 (2001) 50-58
32. Ogata M., Itoh M., and Yamasowa H. Role of nitric oxide in the renal protective effects of ischemic preconditioning. J. Cardiovasc. Pharmacol. 42 (2003) 419-427
33. Firth J.D., and Ratcliffe P.J. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J. Clin. Invest. 90 (1992) 1023-1031
34. Wilhelm S.M., Simonson M.S., and Robinson A.V. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int. 55 (1999) 1011-1018
35. Boulanger C., and Luscher T.F. Release of endothelin from porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990) 587-590
36. Mitsutomi N., Akashi C., and Odagiri J. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur. J. Pharmacol. 364 (1999) 65-73
37. Kurata H., Takaoka M., and Kubo Y. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur. J. Pharmacol. 517 (2005) 232-239